|
American Medical Association |
Precision Medicine for Your Practice: Genomic Testing for the Healthy Individual |
0.5 |
Yes |
1/5/2027 |
|
American Medical Association |
Precision Medicine for Your Practice: Interpreting Results from Somatic Cancer Panel Testing |
0.5 |
Yes |
1/12/2027 |
|
American Medical Association |
Precision Medicine For Your Practice: Prenatal Cell-Free DNA Screening |
0.75 |
Yes |
8/21/2025 |
|
American Medical Association |
Precision Medicine For Your Practice: Prenatal Cell-Free DNA Screening |
0.5 |
Yes |
8/21/2025 |
|
JAMA Psychiatry |
Preexisting Neuropsychiatric Conditions and Associated Risk of Severe COVID-19 Infection and Other Acute Respiratory Infections |
1 |
Yes |
11/14/2025 |
|
JAMA |
Preexposure Prophylaxis for the Prevention of HIV - Updated Evidence Report and Systematic Review for the US Preventive Services Task Force |
1 |
Yes |
8/22/2027 |
|
JAMA |
Preexposure Prophylaxis to Prevent Acquisition of HIV - US Preventive Services Task Force Recommendation Statement |
1 |
Yes |
8/22/2027 |
|
JAMA Network Open |
Preferences for Alternative Care Modalities Among French Adults With Chronic Illness |
1 |
Yes |
1/14/2025 |
|
JAMA |
Prenatal Intravenous Magnesium at 30-34 Weeks' Gestation and Neurodevelopmental Outcomes in Offspring - The MAGENTA Randomized Clinical Trial |
1 |
Yes |
8/15/2026 |
|
Louisiana Medical Mutual Insurance Company (LAMMICO) |
Prescribing Controlled Substances |
2 |
Yes |
4/19/2026 |
|
JAMA |
Prescribing Opioids for Pain |
1 |
Yes |
4/24/2027 |
|
American Association for Physician Leadership |
Presentation Skills for Physician Leaders |
5.0 |
Yes |
10/30/2026 |
|
JAMA Network Open |
Prevalence and Correlates of Long COVID Symptoms Among US Adults |
1 |
Yes |
11/7/2025 |
|
JAMA |
Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy |
1 |
Yes |
2/1/2025 |
|
JAMA |
Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19 |
1 |
Yes |
2/8/2025 |
|
JAMA Network Open |
Prevalence of and Short-term Changes in Conjunctival Manifestations Among Patients With SARS-CoV-2 Infection |
1 |
Yes |
4/22/2025 |
|
JAMA Network Open |
Prevalence of Common Infectious Diseases After COVID-19 Vaccination and Easing of Pandemic Restrictions in Israel |
1 |
Yes |
2/2/2025 |
|
JAMA Network Open |
Prevalence of Positive Rapid Antigen Tests After 7-Day Isolation Following SARS-CoV-2 Infection in College Athletes During Omicron Variant Predominance |
1 |
Yes |
10/26/2025 |
|
JAMA Network Open |
Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2 |
1 |
Yes |
2/4/2025 |
|
American Medical Association |
Preventing Physician Suicide - Identify and Support At-Risk Physicians |
0.5 |
Yes |
5/14/2027 |
